Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-057153 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 15, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
567
Total Value
$753.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer and EVP | Common Stock | โ | Feb 15, 2026 | Exercise/Conversion | 239 | โ | โ | 7,766 | Direct | โ | View Details | |
Chief Scientific Officer and EVP | Common Stock | โ | Feb 15, 2026 | Sale | 89 | $8.47 | $753.83 | 7,677 | Direct | โ | View Details | |
Chief Scientific Officer and EVP | Restricted Stock Units | Derivative | Feb 15, 2026 | Exercise/Conversion | 141 | $0.00 | $0.00 | 563 | Direct | โ | View Details | |
Chief Scientific Officer and EVP | Restricted Stock Units | Derivative | Feb 15, 2026 | Exercise/Conversion | 98 | $0.00 | $0.00 | 780 | Direct | โ | View Details |